Non-Opioid Pain Treatments Likely Not Eligible For Accelerated Approval, US FDA Says

 
• By Derrick Gingery
  
A daily pain diary
Sponsors of non-opioid pain treatments should not rely on observational studies or EMR or claims data during development, draft guidance says. • Source: Alamy

More from Approval Standards

More from Pathways & Standards